Literature DB >> 16806994

ACTH therapy for generalized seizures other than spasms.

Akihisa Okumura1, Takeshi Tsuji, Toru Kato, Jun Natsume, Tamiko Negoro, Kazuyoshi Watanabe.   

Abstract

PURPOSE: We reviewed our experience with ACTH for the treatment of intractable generalized seizures other than spasms.
METHODS: Efficacy and adverse effects of ACTH against intractable generalized seizures other than spasms were retrospectively investigated in 15 patients treated between 1991 and 2003. The median age of the patients at ACTH therapy was 42 months. The targeted type of seizure was brief tonic in 6, atypical absence in 6, atonic in 2, and myoclonic in 1. The dose of ACTH was 0.01-0.015 mg/kg in most patients. The effect of ACTH was determined at the end of ACTH therapy, and 3 months and 1 year after ACTH therapy.
RESULTS: Seizure freedom was obtained in 13 of 15 patients. However, 6 of them had a recurrence of seizures within 3 months after ACTH therapy. ACTH was the most effective in patients with atypical absence seizures. Statistical analysis showed that the number of injection and total dose of ACTH were smaller in patients with atypical absence seizures than in those with brief tonic seizures. Adverse effects were frequent but serious one was not observed.
CONCLUSION: ACTH therapy was effective in patients with intractable generalized seizures other than spasms. However, its efficacy was often transient. ACTH can be useful for generalized seizures other than spasms but its limitation should be considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806994     DOI: 10.1016/j.seizure.2006.05.010

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  7 in total

1.  Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy.

Authors:  Maria Carmela Pera; Giovanna Randazzo; Silvia Masnada; Serena Donetti Dontin; Valentina De Giorgis; Umberto Balottin; Pierangelo Veggiotti
Journal:  Funct Neurol       Date:  2015 Jul-Sep

2.  Focal seizures during adrenocorticotropic hormone therapy in a school-aged boy: a case report.

Authors:  Yoshitaka Ota; Shuichi Shimakawa; Hikaru Tsuda-Kitahara; Miho Fukui; Mitsuru Kashiwagi; Akira Ashida
Journal:  J Med Case Rep       Date:  2022-05-24

Review 3.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

4.  ACTH therapy in refractory generalized epilepsy.

Authors:  Veena Kalra; Suvasini Sharma; Ravindra Arya
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

5.  Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules.

Authors:  Mark William Lopes; Matthew R Sapio; Rodrigo B Leal; Lloyd D Fricker
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

6.  Therapeutic Effects of Adrenocorticotropic Hormone ACTH in Children with Severely Intractable Seizure.

Authors:  Jafar Nasiri; Azam Sarajan; Mehri Salari; Maryam Sedghi
Journal:  Iran J Child Neurol       Date:  2017

7.  Influence of Concentration on Release and Permeation Process of Model Peptide Substance-Corticotropin-From Semisolid Formulations.

Authors:  Wioletta Siemiradzka; Barbara Dolińska; Florian Ryszka
Journal:  Molecules       Date:  2020-06-15       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.